Eurosurveillance banner


Eurosurveillance invites authors to submit papers for a special issue on HIV/AIDS and other sexually transmitted infections (STI) in men who have sex with men (MSM). The topic is in line with the main theme of World AIDS Day 2009 events organised by the European Centre for Disease Prevention and Control and aims at drawing attention to the epidemiological importance of MSM in HIV and other STI and directing the ECDC activities to focus on main risk groups.

Eurosurveillance is planning to publish a special issue on Socio-economic determinants and infections diseases in Europe in spring 2010. For this reason Eurosurveillance invites interested scientists who have research findings in the area to submit papers for review and possible publication. The submission deadline now is 15 November.

The data from 27 European Union countries plus Iceland, Liechtenstein and Norway show that considerable progress has been made in preventing and controlling the disease. The number of newly diagnosed cases and the overall notification rate declined continuously in the past decade, and the notification rate in 2007 was 12% lower than in 2003. In spite of this decline, a total of 84,917 new cases of TB were registered in 2007 and a number of challenges hamper the progress towards the elimination of TB in the EU.

A number of bacterial and viral infections in pregnant women can have serious effects on the unborn child leading to impaired mental and physical health later in life. This week’s issue of Eurosurveillance is dedicated to infectious diseases in pregnancy.

The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.

In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.

Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


In this issue


Home Eurosurveillance Weekly Release  2006: Volume 11/ Issue 50 Article 1 Printer friendly version
Back to Table of Contents
Next

Eurosurveillance, Volume 11, Issue 50, 14 December 2006
Articles

Citation style for this article: Kroneman A, Vennema H, Harris J, Reuter G, von Bonsdorff CH, Hedlund KO, Vainio K, Jackson V, Pothier P, Koch J, Schreier E, Böttiger BE, Koopmans M, Food-borne viruses in Europe network. Increase in norovirus activity reported in Europe. Euro Surveill. 2006;11(50):pii=3093. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3093

Increase in norovirus activity reported in Europe

A Kroneman1 (annelies.kroneman@rivm.nl), H Vennema1, J Harris2, G Reuter3, C-H von Bonsdorff4, K-O Hedlund5, K Vainio6, V Jackson7, P Pothier8, J Koch9, E Schreier9, B Böttiger10, M Koopmans1 on behalf of the “Food-borne viruses in Europe” network

1National Institute for Public Health and the Environment, Bilthoven, the Netherlands
2Health Protection Agency, Centre for Infections, London, United Kingdom
3Regional Laboratory of Virology, National Reference Laboratory of Gastroenteric Viruses, Pécs, Hungary
4Helsinki University Central Hospital, Virology Division, Helsinki, Finland
5Swedish Institute for Infectious Disease Control, Department of Virology, Karolinska Institute, Stockholm, Sweden
6Norwegian Institute of Public Health, Division of Infectious Disease Control, Oslo, Norway
7Health Protection Surveillance Centre, Dublin, Ireland
8University of Dijon, Laboratoire de Virologie, Dijon, France
9Robert Koch Institute, Berlin, Germany
10Department of Virology, Statens Serum Institut, Copenhagen, Denmark

A large increase in norovirus outbreaks in Hungary and Germany was reported to European national health authorities via the Foodborne Viruses in Europe network (FBVE, http://www.eufoodborneviruses.co.uk/DIVINEVENT/DIVIndex.asp) on 24 November and 4 December respectively. Subsequently, an email was sent to all FBVE members requesting a current overview on norovirus outbreaks in their country, and asking for preliminary reports on genotyping.

Thirteen country authorities participate in the FBVE network. Nine of the 11 country authorities which replied to the survey indicated an increase in norovirus activity (outbreaks and/or case reports) in October and/or November 2006 compared with the same period in 2004 and 2005 (Table). In two countries (France and Spain), no increase in norovirus activity was found. Unusually high norovirus activity already in summer 2006 was reported by the Hungarian authorities (thought to be due to a drinking-water related outbreak) as well as the Netherlands, Denmark, Ireland, Finland and Norway.

Table. Reports of norovirus cases and outbreaks across Europe, as provided by an email survey (left) and as reported to the FBVE database (right). Numbers of reports in the email survey were partly estimates, number of reports in the FBVE database are counts.

Country data via email network in FBVE databases
Increasing NoV activity in October and or November or week 40-48? Numbers of outbreaks/ cases in Oct and Nov reported after email request for data Basis of information Outbreaks in Oct and Nov in FBVE database Most recent genetic information in Bionumerics database Genotypes/variants found in Oct and Nov
2006 2005 2004 lab database national surveill. database national 2006 2005 2004
Germany Yes 604 outbreaks 184 outbreaks 514 outbreaks No Yes 134 139 0 Nov 2006 4 G II.4 of which one variant 2006 b and 3 variant 2006a, and 4 other genotypes
Denmark Yes  249 lab samples  38 lab samples  222 lab samples  Yes  No 0 2 2 Sep 2006 2 II.4, both variant 2006a1
Spain2 No  2 outbreaks 6 outbreaks 12 outbreaks     1 3 4 Oct 2006 1 II.4, variant 2006a
Finland Yes ~ 120 cases ~ 10 cases ~ 10 cases Yes No 0 2 0 Sep 2006  
France No 3 outbreaks 1 outbreak  2 outbreaks Yes No 7 1 2 Oct 2006 2 II.4, variant 2006a , 1 other genotype
England and Wales3 Yes 768 outbreaks and round 756 lab samples 83 outbreaks and 281 lab samples 374 outbreaks and 682 lab samples  Yes  Yes 11 54 69 May 2006 43 G II.4 of which 20 2006a, 11 2006b and 12 non a or b
15 non G II.41*
Hungary Yes 81 outbreaks 17 outbreaks 24 outbreaks Yes   21 3 14 Nov 2006 7 G II.4 of which 5 variant 2006b and 2 2006a
Ireland Yes 7 outbreaks 0 outbreaks 22 outbreaks No Yes 11 5 40 Oct 2006  1 G II.4 variant 2006a, 1 other genotype
Italy unknown           1 0 2 Aug 2006  
The Netherlands Yes 36 outbreaks 5 outbreaks 68 outbreaks Yes   36 3 54 Nov 2006 26 G II.4 of which 19 2006a and 7 2006b
Norway Yes ~ 160 cases ~ 65 cases ~ 35 cases Yes No 1 7 0 none  
Sweden Yes ~ 400 cases ~ 50 cases ~ 350 cases Yes No 1 2 0 Oct 2006 1 G II.4, variant 2006a
Slovenia Yes 7 outbreaks 6 outbreaks 5 outbreaks Yes No 0 5 1 Sep 2006  

1Data of number of samples and genotypes not yet in the FBVE sequence database, but sent by email
2Data from Valencia and Catalonia
3Outbreaks reported from virus reference laboratory only. Laboratory data are from England and Wales, these data will include outbreaks and sporadic cases. The routine laboratory data cannot be linked to the data from the reference lab

The norovirus isolates causing 108 outbreaks which started in October and November 2006 have been characterised, and 87 (81%) belonged to genotype G.II 4, which has been the predominant genotype in recent years. Twenty-one (19%) belonged to other genotypes. Of the 87 G II.4 isolates characterised, 51 (47%) were G II.4 new variant 2006a and 24 (22%) were variant 2006b1. Twelve G II.4 isolates (11%) could not be assigned to a variant.

All norovirus outbreak isolates which were reported to FBVE sequence database in the seasons 2004/2005, 2005/2006 and the present season so far are shown (Figure). The first new variants of genotype GII.4 2006 appeared during the 2005/2006 season, and became the predominant strain in summer 2006. For variant 2006a, the first entry in the database is from an outbreak or case in England in 2005. The first 2006b variant was reported from Spain in December 2005 after an outbreak in a residential institution. In the spring of 2006, this variant was found to be circulating widely, causing at least 45 outbreaks of norovirus illness on cruise ships sailing across Europe. It is believed that the emergence of the variants 2006a and 2006b and the increase in outbreaks on cruise ships might well be the forewarning of a very active norovirus season. This prediction is based on observations in 1996, 2002 and 2004, when the appearance of new variants within genotype GII.4 coincided with high levels of outbreak reporting worldwide [1,2,4].

Figure. Genotypes/variants in seasons 2004/5, 2005/6 and the start of 2006/7
Using all genetic information in the Bionumerics database:
- from outbreaks and from sequences submitted without background data (this last group is small)
- from sequences of part of the polymerase gene (ORF 1) and 2 different non overlapping regions of the capsid gene (ORF2).

2006/2007 norovirus season likely to see high activity

The different country reports indicate that the norovirus season has already started in most areas. As predicted, 2006/2007 is likely to be a highly active norovirus season, with the new variants of genotype G II.4 2006 being predominant [3]. It is therefore recommended that hospitals and nursing homes inform their staff about the possibility of norovirus outbreaks and provide information on the clinical presentation. They should also consult their outbreak protocols, adopt them if necessary and strengthen preventive measures, in order to be prepared for the present outbreak season.

The data provided in response to this email survey come from local datasets, and are not (yet) visible in the FBVE database. The FBVE network maintains a web-based database to which 13 national authorities report norovirus outbreaks, along with epidemiological and laboratory data. The average delay between the onset of an outbreak and the reporting of this outbreak to the FBVE database is quite long. For the outbreaks reported in the quarterly period of July to September 2006, the average delay was 111 days, ranging from 23 days (Sweden) to 436 days (Italy). As a result, in its present form, the FBVE database can not be used to compare reports from Germany and Hungary with the rest of the European situation. Since typing norovirus strains takes some time, there is limited information on the circulating noroviruses at the moment. A complete comparison will be possible towards the end of this winter.

*Correction 15 December. The original text incorrectly stated '15 non G II.42'

Footnote. Comparisons of genome sequences to determine if norovirus outbreak strains elsewhere belong to the same new variant lineage can be done via an open access strain matching system (http://www.rivm.nl/bnwww). This was established by the FBVE network to allow harmonized sequence comparisons worldwide for commonly used genome regions (follow the links to ‘Food-borne viruses in Europe’ and ‘quick typing database’. Requests for strain comparison can also be sent to fbve@rivm.nl).

References:
  1. Bull RA, Tu ET, McIver CJ, Rawlinson WD, White PA. Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis. J Clin Microbiol. 2006 Feb;44(2):327-33.
  2. Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A, et al. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet. 2004 Feb 28;363(9410):682-8.
  3. Koopmans M, Harris J, Verhoef L, Depoortere E, Takkinen J, Coulombier D; International Outbreak Investigation Team. European investigation into recent norovirus outbreaks on cruise ships: update. Euro Surveill 2006; 11(7) E060706.5 (http://www.eurosurveillance.org/ew/2006/060706.asp#5)
  4. Noel JS, Fankhauser RL, Ando T, Monroe SS, Glass RI. Identification of a distinct strain of “Norwalk-like Viruses” having a global distribution. J Infect Dis. 1999 Jun;179(6):1334-44.
  5. Takkinen J. Recent norovirus outbreaks on river and seagoing cruise ships in Europe. Euro Surveill 2006;11(6):E060615.2. Available from: http://www.eurosurveillance.org/ew/2006/060615.asp#2
  6. RKI: Norovirus-Gastroenteritiden haben in den letzten Wochen deutlich zugenommen - steht eine neue Winterepidemie bevor? Epid Bull 2006;48:427-429.
    http://www.rki.de/cln_006/nn_226928/DE/Content/Infekt/EpidBull/Archiv/2006/48__06,templateId=raw,property=publicationFile.pdf/48_06
  7. Verhoef L, Depoortere E, Vennema H, Duizer E, Kroneman A, Harris J, et al, on behalf of the Foodborne Viruses in Europe network. Norovirus outbreaks on cruise ships sailing in European waters: what is the underlying cause? (manuscript in preparation 2006).

back to top



Back to Table of Contents
Next

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our Website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2008 All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.